Cargando…

Association of Age with Mortality Rate after Femoropopliteal Endovascular Therapy for Intermittent Claudication

Aim: This study aimed to reveal the mortality risk by age in patients undergoing femoropopliteal endovascular therapy for intermittent claudication, in comparison to the national age-specific standard value. Methods: We analyzed 2056 patients undergoing endovascular therapy for moderate to severe in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahara, Mitsuyoshi, Soga, Yoshimitsu, Fujihara, Masahiko, Kawasaki, Daizo, Kozuki, Amane, Iida, Osamu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090479/ https://www.ncbi.nlm.nih.gov/pubmed/33642442 http://dx.doi.org/10.5551/jat.62356

Ejemplares similares

Inverse association of diabetes and dialysis with the severity of femoropopliteal lesions and chronic total occlusion: a cross-sectional study of 2056 cases
por: Takahara, Mitsuyoshi, et al.
Publicado: (2020)

Mortality risk of femoropopliteal paclitaxel-coated devices remains inconclusive
por: Takahara, Mitsuyoshi, et al.
Publicado: (2019)

Association of Smoking, Diabetes, and Dialysis with the Presence of Popliteal Lesions in Femoropopliteal Artery Disease
por: Takahara, Mitsuyoshi, et al.
Publicado: (2023)

Vessel Patency and Associated Factors of Drug‐Coated Balloon for Femoropopliteal Lesion
por: Soga, Yoshimitsu, et al.
Publicado: (2022)

Prognostic Value of the CHA (2) DS (2) -VASc Score after Endovascular Therapy for Femoral Popliteal Artery Lesions
por: Tomoi, Yusuke, et al.
Publicado: (2021)

Impact of postprocedural minimum lumen area on clinical outcome after femoropopliteal drug-eluting stent implantation
por: Haraguchi, Takuya, et al.
Publicado: (2023)

Subintimal Versus Intraluminal Approach for Femoropopliteal Chronic Total Occlusions Treated With Intravascular Ultrasound Guidance
por: Tomoi, Yusuke, et al.
Publicado: (2021)

Sodium-glucose co-transporter 2 inhibitor use in patients with diabetes mellitus undergoing endovascular therapy for symptomatic peripheral artery disease
por: Takahara, Mitsuyoshi, et al.
Publicado: (2023)

Ten-Year Clinical Follow-Up Following Bare-Nitinol Stent Implantation for Femoropopliteal Artery Disease
por: Soga, Yoshimitsu, et al.
Publicado: (2022)

One-Year Late Lumen Loss between A Polymer-Coated Paclitaxel-Eluting Stent (Eluvia) and a Polymer-Free Paclitaxel-Coated Stent (Zilver PTX) for Femoropopliteal Disease
por: Soga, Yoshimitsu, et al.
Publicado: (2020)

Application of first-generation high- and low-dose drug-coated balloons to the femoropopliteal artery disease: a sub-analysis of the POPCORN registry
por: Fujihara, Masahiko, et al.
Publicado: (2023)

Outcomes of endovascular treatment of patients with intermittent claudication due to femoropopliteal disease
por: Naiem, Ahmed A, et al.
Publicado: (2021)

Intravascular ultrasound-based decision tree model for the optimal endovascular treatment strategy selection of femoropopliteal artery disease—results from the ONION Study-
por: Yazu, Yuko, et al.
Publicado: (2022)

Presentation Pattern of Lower Extremity Endovascular Intervention versus Percutaneous Coronary Intervention
por: Takahara, Mitsuyoshi, et al.
Publicado: (2020)

Clinical Impact of Additional Cilostazol Treatment on Restenosis Risk following Heparin-Bonded Stent Graft Implantation: Sub-Analysis from the Viabahn Stent-Graft Placement for Femoropopliteal Diseases Requiring Endovascular Therapy (VANQUISH) Study
por: Tobita, Kazuki, et al.
Publicado: (2023)

In-Hospital Outcomes after Endovascular Therapy for Acute Limb Ischemia: A Report from a Japanese Nationwide Registry [J-EVT Registry]
por: Tsujimura, Takuya, et al.
Publicado: (2021)

One-Year Clinical Outcomes following Implantation of Innova™ Self-Expanding Nitinol Stents in Patients with Peripheral Artery Diseases Presenting Femoropopliteal Artery Lesions
por: Tsujimura, Takuya, et al.
Publicado: (2019)

Diabetes mellitus and other cardiovascular risk factors in lower-extremity peripheral artery disease versus coronary artery disease: an analysis of 1,121,359 cases from the nationwide databases
por: Takahara, Mitsuyoshi, et al.
Publicado: (2019)

Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia: The SPINACH Study (Surgical Reconstruction Versus Peripheral Intervention in Patients With Critical Limb Ischemia)
por: Iida, Osamu, et al.
Publicado: (2017)

Ambulatory Status Over Time after Revascularization in Patients with Chronic Limb-Threatening Ischemia
por: Kodama, Akio, et al.
Publicado: (2022)

Role of the latest endovascular technology in the treatment of intermittent claudication
por: Ichihashi, Shigeo, et al.
Publicado: (2014)

Impact of homocysteine levels on mortality risk in patients with chronic limb-threatening ischemia undergoing revascularization
por: Takahara, Mitsuyoshi, et al.
Publicado: (2021)

Intermittent Claudication
Publicado: (1908)

Effect of Target Lesion Revascularization on Restenosis Lesions of the Superficial Femoral Artery without Recurred Symptoms after Endovascular Therapy
por: Utsunomiya, Makoto, et al.
Publicado: (2021)

Clinical Impact of Measures for Frailty Severity in Poor-Risk Patients Undergoing Revascularization for Chronic Limb-Threatening Ischemia
por: Takahara, Mitsuyoshi, et al.
Publicado: (2022)

Paclitaxel and mortality in patients with claudication and de novo femoropopliteal lesions: a historical cohort study
por: Gahide, Gérald, et al.
Publicado: (2021)

The Association of Preoperative Characteristics with Reintervention Risk in Patients Undergoing Revascularization for Chronic Limb-Threatening Ischemia
por: Iida, Osamu, et al.
Publicado: (2021)

Current and Past Obesity in Japanese Patients with Critical Limb Ischemia Undergoing Revascularization
por: Takahara, Mitsuyoshi, et al.
Publicado: (2021)

Social isolation in patients with chronic limb-threatening ischemia: a cross-sectional study
por: Takahara, Mitsuyoshi, et al.
Publicado: (2023)

Injury Precipitating Tissue Loss and Time to Referral to a Vascular Center in Patients with Chronic Limb-Threatening Ischemia
por: Takahara, Mitsuyoshi, et al.
Publicado: (2023)

Algorithm of Femoropopliteal Endovascular Treatment
por: Dubosq, Maxime, et al.
Publicado: (2022)

Intermittent Claudication in Hypertensive Men
por: Ramsay, L. E.
Publicado: (1979)

Infographic. Exercise for intermittent claudication
por: Tew, Garry A, et al.
Publicado: (2020)

Intermittent Claudication in Physiotherapists' Practice
por: Spannbauer, Anna, et al.
Publicado: (2019)

Heterogeneity of Age and Its Associated Features in Patients with Critical Limb Ischemia
por: Takahara, Mitsuyoshi, et al.
Publicado: (2020)

Comparison of Clinical Outcomes after Surgical and Endovascular Revascularization in Hemodialysis Patients with Critical Limb Ischemia
por: Shiraki, Tatsuya, et al.
Publicado: (2017)

Quality of life in patients with intermittent claudication
por: Harwood, A. E., et al.
Publicado: (2017)

Exercise prescription using the heart of claudication pain onset in patients with intermittent claudication
por: Cucato, Gabriel Grizzo, et al.
Publicado: (2013)

Diabetes mellitus and intermittent claudication: a cross-sectional study of 920 claudicants
por: Lozano, Francisco S, et al.
Publicado: (2014)

The Edinburgh Claudication Questionnaire has poor diagnostic accuracy in people with intermittent claudication
por: Ibeggazene, Saïd, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9fcgvo2pffe2gtkt8l5jvle6eq